Search - tctmd.com

Displaying 101 - 120 of 153

Sort: Relevancy | Date

Presentation TCT 2014

No: Another Misguided Effort Keeping Patients Away from a Superior Operation!

Presenter: Sanjay Kaul, Ajay J. Kirtane, David Taggart

September 13, 2014

Presentation TCT 2014

Yes: The Time Has Come for Physiology-Guided Revascularization!

Presenter: Sanjay Kaul, Ajay J. Kirtane, Nick Curzen

September 13, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

Presentation TCT 2013

Cases VII and VIII: Multivessel Disease (and the Functional Syntax Score)

Presenter: Chang-Wook Nam

October 31, 2013

Presentation TCT 2013

Case #2 - PCI in a Patient with 3 Vessel Disease: Is the Syntax 2 Score Helpful in Decision-Making?

Presenter: Milan Nedeljkovic

October 31, 2013

News Conference News TCT 2013

Vasim Farooq, MD, Wins Linnemeier Young Investigator Award

October 31, 2013

News Conference News TCT 2013

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

October 30, 2013

News Conference News TCT 2013

PCI vs. CABG a Close Call in Some Complex Patients

October 30, 2013

Presentation TCT 2013

The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial

Presenter: Mahesh V. Madhavan

October 29, 2013

Presentation TCT 2013

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Presenter: Yuejin Yang

October 29, 2013

Presentation TCT 2013

Case Presentation Introduction: A Patient with 3VD, Low/Intermediate SYNTAX Score, Moderate Symptoms and Moderate Ischemia by SPECT-MPS

Presenter: Michael Kutcher

October 29, 2013

Presentation TCT 2013

Case Presentation Introduction: A Patient with 3VD, Intermediate/High SYNTAX Score, Type II Diabetes, Moderate Co-Morbidiites adn Moderate Symptoms

Presenter: Antonio Colombo

October 29, 2013

News Conference News TCT 2013

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

Presentation TCT 2013

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Presenter: Dean Kereiakes

October 28, 2013

Presentation TCT 2013

Yes! But the Biggest Change Is FFR: The Functional Syntax Score Should Guide Revascularization Decisions

Presenter: William Fearon

October 28, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Pros and Cons of SYNTAX Score II

Presenter: Davide Capodanno

October 28, 2013

Presentation TCT 2013

PCI vs CABG Rrisk-stratification: Is the SYNTAX Score II the Final Aarbiter...for Now?

Presenter: Patrick Serruys

October 28, 2013

Advertisement

No: Another Misguided Effort Keeping Patients Away from a Superior Operation!

Yes: The Time Has Come for Physiology-Guided Revascularization!

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Cases VII and VIII: Multivessel Disease (and the Functional Syntax Score)

Case #2 - PCI in a Patient with 3 Vessel Disease: Is the Syntax 2 Score Helpful in Decision-Making?

Vasim Farooq, MD, Wins Linnemeier Young Investigator Award

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

PCI vs. CABG a Close Call in Some Complex Patients

The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Case Presentation Introduction: A Patient with 3VD, Low/Intermediate SYNTAX Score, Moderate Symptoms and Moderate Ischemia by SPECT-MPS

Case Presentation Introduction: A Patient with 3VD, Intermediate/High SYNTAX Score, Type II Diabetes, Moderate Co-Morbidiites adn Moderate Symptoms

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Yes! But the Biggest Change Is FFR: The Functional Syntax Score Should Guide Revascularization Decisions

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Pros and Cons of SYNTAX Score II

PCI vs CABG Rrisk-stratification: Is the SYNTAX Score II the Final Aarbiter...for Now?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content